Cargando…
LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma
AIMS: Glioblastoma (GBM) is the most common malignant brain tumor with an adverse prognosis in the central nervous system. Traditional histopathological diagnosis accompanied by subjective deviations cannot accurately reflect tumor characteristics for clinical guidance. DNA methylation plays a criti...
Autores principales: | Ma, Wenping, Bao, Zhaoshi, Qian, Zenghui, Zhang, Kenan, Fan, Wenhua, Xu, Jianbao, Ren, Changyuan, Zhang, Ying, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062568/ https://www.ncbi.nlm.nih.gov/pubmed/35338570 http://dx.doi.org/10.1111/cns.13817 |
Ejemplares similares
-
Comprehensive transcriptomic characterization reveals core genes and module associated with immunological changes via 1619 samples of brain glioma
por: Zhang, Ying, et al.
Publicado: (2021) -
A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma
por: Fan, Wenhua, et al.
Publicado: (2022) -
SAMD9 Is Relating With M2 Macrophage and Remarkable Malignancy Characters in Low-Grade Glioma
por: Ma, Wenping, et al.
Publicado: (2021) -
KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4
por: Sun, Lihua, et al.
Publicado: (2016) -
Multidisciplinary Roles of LRRFIP1/GCF2 in Human Biological Systems and Diseases
por: Takimoto, Masato
Publicado: (2019)